Martin Buck

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial

Robert L. Coleman, Amit M. Oza, Domenica Lorusso et al. · The Lancet · 2017 · 1.7K citations · Full text

Medicine, Gynecology, Oncology +12

Engineering modular and orthogonal genetic logic gates for robust digital-like synthetic biology

Baojun Wang, R.I. Kitney, Nicolas Joly et al. · Nature Communications · 2011 · 443 citations · Full text

Engineering, Bioengineering, Biotechnology +17

Cisplatin and Gemcitabine Treatment for Malignant Mesothelioma: A Phase II Study

Michael Byrne, Jennifer Davidson, Arthur W. Musk et al. · Journal of Clinical Oncology · 1999 · 335 citations

Medicine, Oncology, Radiology +16

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

Olga Kondrashova, Monique Topp, Ksenija Nesic et al. · Nature Communications · 2018 · 292 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Upstream activator sequences are present in the promoters of nitrogen fixation genes

Martin Buck, Stephen C. Miller, Martin Drummond et al. · Nature · 1986 · 287 citations

Life Sciences, Genetics, Molecular Biology +14